All lobbying filings

INNOVATIVE FEDERAL STRATEGIES, LLC

Lobbying for CERUS CORPORATION

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$40,000.00

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 4

Executive Office of the President (EOP)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 6

HR 4016
Department of Defense Appropriations Act, 2026
S 2572
Department of Defense Appropriations Act, 2026
HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
S 2296
National Defense Authorization Act for Fiscal Year 2026

Lobbying activity 3

Health Issues

Contacted officials regarding the Red Blood Cell Clinical Trial Program and blood safety issues.

Budget/Appropriations

H.R.4016/S.2572 Department of Defense Appropriations Bill, 2026, Title VI, all provisions related to blood safety. H.R.5304/S.2587 Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2026 - Title II, all provisions related to blood safety.

Defense

H.R.3838/S.2296 National Defense Authorization Act, 2026, Title XIV, all provisions related to blood safety.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.